Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Sep;76(9):1286–1288. doi: 10.1136/jnnp.2004.053686

Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?

F-E de Leeuw 1, F Barkhof 1, P Scheltens 1
PMCID: PMC1739776  PMID: 16107369

Abstract

Objective: To investigate the prevalence and risk factors for progression of WML in Alzheimer's disease.

Subjects: 38 patients with Alzheimer's disease for whom blood pressure measurements and sequential brain MRIs were available.

Methods: The proportion of patients with progression of WML was calculated, stratified on baseline absence or presence of WML by analysis of variance. Odds ratios (OR) were calculated by age and sex adjusted logistic regression to quantify the relation between blood pressure and progression of WML.

Results: About 25% of the patients showed progression of WML. Patients with WML at baseline had significantly more progression than those without WML at baseline (adjusted mean difference = 1.2; 95% confidence interval (CI), 0.6 to 1.8). Diastolic blood pressure (DBP) was particularly related to progression of WML (OR = 5.9 (95% CI, 1.0 to 37.6) per 10 mm Hg DBP, p = 0.05).

Conclusions: Alzheimer's disease patients with WML at baseline are at risk for rapid progression of WML. WML may offer a potential treatment target in this disease to ameliorate the rate of cognitive decline.

Full Text

The Full Text of this article is available as a PDF (135.9 KB).


Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES